bis(1-piperidylthiocarbonyl)disulfide has been researched along with thiram in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Buckheit, RW; Clanton, D; Covell, DG; Graham, L; Rice, WG; Schaeffer, CA; Summers, MF; Turpin, JA; Wallqvist, A; Zaharevitz, D | 1 |
| Kapanda, CN; Labar, G; Lambert, DM; Muccioli, GG; Poupaert, JH | 1 |
| Bala, V; Gupta, G; Jain, A; Jangir, S; Krishna, S; Kumar, L; Kushwaha, B; Lal, N; Maikhuri, JP; Mandalapu, D; Pandey, AK; Rawat, T; Sarswat, A; Sharma, VL; Shukla, PK; Siddiqi, MI | 1 |
| Chen, X; Huang, YY; Li, J; Li, XK; Mao, F; Ni, SS; Ren, YL; Song, RR; Wan, J; Xu, YX; Zhang, C; Zhu, J | 1 |
| Omran, Z | 1 |
5 other study(ies) available for bis(1-piperidylthiocarbonyl)disulfide and thiram
| Article | Year |
|---|---|
Evaluation of selected chemotypes in coupled cellular and molecular target-based screens identifies novel HIV-1 zinc finger inhibitors.
Topics: Anti-HIV Agents; Binding Sites; Cells, Cultured; Disulfides; Guanidines; HIV-1; Humans; Hydrazines; Macrophages; Models, Molecular; Molecular Structure; Monocytes; RNA, Messenger; Virus Replication; Zinc Fingers | 1996 |
Bis(dialkylaminethiocarbonyl)disulfides as potent and selective monoglyceride lipase inhibitors.
Topics: Amidohydrolases; Disulfides; Enzyme Activation; Enzyme Inhibitors; Humans; Inhibitory Concentration 50; Monoacylglycerol Lipases; Mutation; Nitrogen; Oxidation-Reduction; Structure-Activity Relationship; Substrate Specificity | 2009 |
Role of disulfide linkage in action of bis(dialkylaminethiocarbonyl)disulfides as potent double-Edged microbicidal spermicide: Design, synthesis and biology.
Topics: Animals; Anti-Infective Agents; Candida; Disulfides; Male; Mice; Rabbits; Spermatocidal Agents; Spermatozoa; Trichomonas vaginalis | 2016 |
Development of disulfide-derived fructose-1,6-bisphosphatase (FBPase) covalent inhibitors for the treatment of type 2 diabetes.
Topics: Animals; Blood Glucose; Cysteine; Diabetes Mellitus, Type 2; Disulfides; Enzyme Inhibitors; Fructose-Bisphosphatase; Male; Mice; Structure-Activity Relationship | 2020 |
Development of new disulfiram analogues as ALDH1a1-selective inhibitors.
Topics: Acetaldehyde Dehydrogenase Inhibitors; Alcohol Deterrents; Aldehyde Dehydrogenase 1 Family; Aldehyde Dehydrogenase, Mitochondrial; Disulfiram; Enzyme Assays; Humans; Retinal Dehydrogenase; Substrate Specificity | 2021 |